Cycurion is trading 7.38% down at $3.33, reversing part of its sharp recent rally; no company-specific negative announcement was identified to explain the September 4, 2026 decline.
- The latest reported catalyst was approximately $800,000 in annualized contracts announced September 3, covering pharmaceutical AI, public-health, cybersecurity, and commercial work.
- Software stocks were higher while major indexes were mixed to lower; today’s move appears to be an unclear pullback rather than a confirmed sector or macro reaction.